Discounted Cash Flow (DCF) Analysis Levered
vTv Therapeutics Inc. (VTVT)
$0.8156
+0.00 (+0.10%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 12.43 | 2.76 | 6.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | -26.86 | -23.02 | -18 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -0 | -0.07 | -0.08 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | -26.86 | -23.09 | -18.08 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Weighted Average Cost Of Capital
Share price | $ 0.8,156 |
---|---|
Beta | -1.197 |
Diluted Shares Outstanding | 47.14 |
Cost of Debt | |
Tax Rate | 22.95 |
After-tax Cost of Debt | 0.00% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | -1.866 |
Total Debt | 0.72 |
Total Equity | 38.45 |
Total Capital | 39.16 |
Debt Weighting | 1.83 |
Equity Weighting | 98.17 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 12.43 | 2.76 | 6.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | -26.86 | -23.02 | -18 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Capital Expenditure | -0 | -0.07 | -0.08 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
Free Cash Flow | -26.86 | -23.09 | -18.08 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
WACC | ||||||||||
PV LFCF | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | ||||
SUM PV LFCF | -0.05 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | -1.83 |
Free cash flow (t + 1) | -0.01 |
Terminal Value | 0.18 |
Present Value of Terminal Value | 0.20 |
Intrinsic Value
Enterprise Value | 0.15 |
---|---|
Net Debt | -11.41 |
Equity Value | 11.56 |
Shares Outstanding | 47.14 |
Equity Value Per Share | 0.25 |